Drug Manufacturers

Drugmakers tout AI efforts at conference amid US tariffs concerns

Drugmakers such as Amgen and contract manufacturers including Parexel highlighted AI's role in reducing the time taken to conduct certain parts of the trials

Trump threatens drugmakers with tariffs if they don't move production to US

Trump also didn't commit to pushing Congress to water down a drug pricing programme enacted under President Joe Biden that the pharmaceutical industry has been seeking relief from

CDSCO flags 135 drugs for failing quality standards for December 2024

Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, Himachal Pradesh's Baddi, Puducherry, Roorkee and Haridwar

Eli Lilly to buy cancer drugmaker Scorpion Therapeutics for up to $2.5 bn

Lilly will acquire Scorpion's experimental oral therapy, STX-478, which is currently being tested in early-stage trials for breast cancer and other advanced solid tumors

111 drug samples tested in November found 'not of standard quality': CDSCO

Central Drugs Standard Control Organisation (CDSCO) has found 41 drug samples tested in the central drug laboratories in November as 'not of standard quality' (NSQ), official sources said. Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they said. Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. "The failure is specific to the drug products of the batch tested by the government laboratory and it does not warrant any concerns on the other drug products available in the market," an official said. Two drug samples were identified as spurious drugs in November. Out of the two samples, one was picked by Bihar Drugs Control Authority and the other by CDSCO, Ghaziabad, the sources said. The drugs were made by unauthorised and unknown manufacturers, using brand names of other companies. Action to identify NSQ and spurious medicines is ta

AstraZeneca withdraws EU application for experimental lung cancer drug

Feedback from the EU indicated that the trial results, which the application was based on, showed that the drug did not significantly improve overall survival for patients

Ex Pfizer CEO, CFO not to involve in Starboard's campaign on drugmaker

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink

'India's pharma exports expected to remain strong amid global slowdown'

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal despite a slowdown in the global economy, a senior government official said on Wednesday. With the government revving up support for drug development in India, as many as 16 blockbuster molecules targeted for a wide range of therapeutic areas, including cancer, diabetes, HIV and tuberculosis, are in the pipeline to be produced in India, Department of Pharmaceuticals, Secretary Arunish Chawla told reporters on the sidelines of CII Pharma and Life Sciences summit here. "We have been analysing the export trends in the recent data. Even though there is a general slowdown in exports globally, the good news is that the Indian pharmaceuticals, biotech, and bulk drug exports have grown double-digit over the last year," he said in response to a query on export prospects of the pharma industry amid a global slowdown. He further said,"In the first four months of this year, .

India considers blue strips for antimicrobials to combat drug misuse

Antimicrobial resistance (AMR) occurs when bacteria and other pathogens develop resistance to antibiotics or other drugs, rendering these medicines ineffective when needed most

Abbott India Q1 results: PAT rises 13% to Rs 328 cr, income at Rs 1,625 cr

Drug firm Abbott India on Wednesday said its net profit increased by 13 per cent year on year to Rs 328 crore for the first quarter ended June 30, 2024. The company reported a net profit of Rs 290 crore in the April-June quarter of last fiscal. Total income rose to Rs 1,625 crore for the period under review as against Rs 1,535 crore in the June quarter of FY24, Abbott India said in a regulatory filing. Shares of the company on Wednesday ended 1.29 per cent up at Rs 28,159.95 apiece on the BSE.

Govt plans regulatory crackdown on similar-sounding, look-alike drug brands

Drug manufacturers in India will soon be required to upload their product formulations and brand names on the government's portal

AstraZeneca raises sales and profit forecast as demand for therapies grows

AstraZeneca's drug pipeline has evolved significantly under CEO Pascal Soriot since he took over more than a decade ago

Centre fails to form policy on online sale of drugs ahead of HC deadline

The Delhi HC had in March this year, given the government a final opportunity to frame a policy within four months, failing which, the court had stated it would hear the matter on merits

Govt planning regulatory crackdown on look-alike, sound-alike drug names

In order to safeguard patients, the Drug Technical Advisory Board (DTAB) proposed banning the production and marketing of distinct drugs under identical brand names

Medical device bodies welcome CDSCO order on self-reporting adverse effects

The drug regulator stated that medical device manufacturers need to take appropriate action for timely reporting of adverse events related to medical devices to MvPI

Former prez of Honduras convicted in US of aiding drug traffickers

Former Honduran President Juan Orlando Hernndez was convicted on Friday in New York of charges that he conspired with drug traffickers and used his military and national police force to enable tons of cocaine to make it unhindered into the United States. The jury returned its verdict at a federal court after a two week trial, which has been closely followed in his home country. Hernndez, 55, served two terms as the leader of the Central American nation of roughly 10 million people. He was arrested at his home in Tegucigalpa, the Honduran capital, three months after leaving office in 2022 and was extradited to the US in April of that year. US prosecutors accused Hernndez of working with drug traffickers as long ago as 2004, saying he took millions of dollars in bribes as he rose from rural congressman to president of the National Congress and then to the country's highest office. Hernndez acknowledged in trial testimony that drug money was paid to virtually all political parties in

Strides Pharma receives USFDA approval for neurology medication Gabapentin

Gabapentin is widely used in managing neuropathic pain associated with diabetic neuropathy, postherpetic neuralgia, and central pain

Medical groups raise concerns around India-EFTA after leaked documents

Doctors Without Borders (MSF), Public Eye, and Delhi Network of Positive People expressed concern that the deal, which is nearing completion, includes harmful intellectual property (IP) proposals

Glenmark Pharma Q3 results: Standalone loss at Rs 20 cr, revenue dips 38.4%

Glenmark is going through a transitionary phase on account of divestment of Glenmark Life Sciences, says MD

Budget to boost healthcare sector, bolster bulk drug manufacturing: Expert

India's interim Budget would help in addressing some of the major challenges being faced by the country in the health and pharma sector and reinforce India's standing as the Pharmacy of the World, a well-known pharma industry association head has said. The Union Health Ministry has been allocated Rs 90,658.63 crore in the interim Budget for 2024-2025, a hike of 12.59 per cent over 80,517.62 crore in the Budget (revised estimates) for 2023-2024. Finance Minister Nirmala Sitharaman said the government plans to set up more medical colleges by utilising existing hospital infrastructure and will form a committee to examine the issues and make relevant recommendations. India's commitment to promoting research and development in the life sciences sector will receive a boost with the government's plan to establish more medical colleges in the country, Karun Rishi, president of the USA India Chamber of Commerce said on Thursday. "This initiative will improve healthcare services and contribu